Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2023224.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a patient with systemic lupus erythematosus (SLE) complicated by severe autoimmune hemolytic anemia. Therapy with corticosteroids, splenectomy, azathioprine, chlorambucil, and intravenous immunoglobulin was unsuccessful. She responded to danazol, however, with maintenance of her hemoglobin and reductions in her transfusion and corticosteroid requirement. Thus, danazol may represent an important therapeutic option in the treatment of autoimmune hemolytic anemia.
Medical subject headings
- Anemia, Hemolytic, Autoimmune
- Danazol
- Lupus Erythematosus, Systemic